Abid Ansari has extensive experience in financial leadership within the biotechnology and pharmaceutical sectors. Currently serving as a Financial Advisor at Tellus Therapeutics, Inc., Abid previously held the position of Chief Financial Officer at OncoC4, Inc., Artios Pharma Ltd, and Precision BioSciences, Inc. Additionally, Abid contributed to GSK as Sr. Director of Deal Finance and M&A in the World Wide Business Development team, as well as Sr. Director and Head of the Portfolio Analysis Group in R&D. Abid Ansari's educational background includes studying at Purdue University from 1996 to 2001 and Goldey-Beacom College from 2003 to 2006, earning an Accounting Minor and CPA in Delaware.